Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

ENZ
Enzo Biochem, Inc.
stock NYSE

At Close
3/27/2023 4:00:02 PM EDT
2.24USD+3.226%(+0.07)255,729
1.77Bid   2.68Ask   0.91Spread IEX
Pre-market
3/24/2023 8:49:30 AM EDT
2.09USD-3.668%(-0.08)0
After-hours
3/27/2023 4:00:30 PM EDT
2.24USD0.000%(0.00)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
111.245M
CEO
Elazar Rabbani
Headquarters
Farmingdale, New York, USA
Industry
Diagnostics & Research
Next Earnings
2023-06-08 (72d)
Last Split
2004-10-2021for20
Related
PMDRDNTDGXLHNEOQGENXLV
ENZ Stats
Avg. Vol. 10 Day
1,601,054
Avg. Vol. 30 Day
599,768
Employees
465
Market Cap
111,244,719
Shares Out.
49,662,821
Float
34,795,262
P/E Ratio
-4.05
EPS (ttm)
-0.546
On/Off Exchange
47%/53%
6 Month Beta
0.10
1 Year Beta
0.31
2 Year Beta
0.40
3 Year Beta
0.63
52 Week Low
1.00
52 Week High
3.06
SMA50
1.35
SMA200
1.76
1 Month
+96.49%
3 Month
+83.61%
6 Month
+6.67%
1 Year
-25.08%
2 Year
-34.88%
5 Year
-58.82%
Jan 21, 2022
04:19PM EST  Enzo Biochem 8-K Shows Co. Co-Founder, Chair, Chief Scientific Officer Elazar Rabbani Was Terminated   Benzinga
Jan 3, 2022
04:10PM EST  Hamid Erfanian and Bradley Radoff Appointed to Enzo   GlobeNewswire Inc
Dec 16, 2021
08:20AM EST  The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street   Benzinga
Dec 15, 2021
04:08PM EST  Enzo Biochem Q1 EPS $(0.05) Down From $0.01 YoY, Sales $26.50M Down From $28.66M YoY   Benzinga
04:05PM EST  -- 1Q FY 2022 revenues of $26.5 million vs. $24.8 million in 4Q FY 2021, representing a 7% sequential increase -- Company appoints Hamid Erfanian as Chief Executive Officer -- Consolidated manufacturing footprint at state-of-the-art Farmingdale, NY campus to enhance operational efficiencies   GlobeNewswire Inc
More News
Profile
Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products, systems and services that meet the ever-changing and rapidly growing needs of health care today and into the future. Underpinning Enzo Biochem's products and technologies is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies.

ENZ Stock Summary

Enzo Biochem, Inc. (NYSE:ENZ) stock price today is $2.24, and today's volume is 255,729. ENZ is up 3.226% today. The 30 day average volume is 599,768. ENZ market cap is 111.245M with 49,662,821 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC